Form 4: Definitive Healthcare EVP, Chief Data Officer Benjamin Graboske Reports Acquisition of Restricted Stock Units

Benjamin Graboske, EVP and Chief Data Officer of Definitive Healthcare Corp., reports the acquisition of restricted stock units representing a contingent right to receive Class A Common Stock.

Summary

• On March 3, 2025, Benjamin Graboske, EVP, Chief Data Officer of Definitive Healthcare Corp., reported a transaction involving restricted stock units (RSUs).
• The RSUs represent a contingent right to receive one share of the Issuer's Class A Common Stock.
• A total of 1,018,330 RSUs were acquired.
• 25% of the RSUs vest on April 1, 2026, followed by 6.25% vesting every three months thereafter over the subsequent three years, contingent upon continued service with the Issuer.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns executive interests with the company's long-term performance.

Positives

• The vesting schedule incentivizes continued service and alignment with the company's long-term success.

Risks

• The value of the RSUs is contingent on the price of Definitive Healthcare's Class A Common Stock.
• The vesting of the RSUs is dependent on the Reporting Person's continued service with the Issuer.

Future Outlook

The vesting schedule extends over three years, indicating a long-term incentive for the Reporting Person.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies.

Stakeholder Impact

• The vesting schedule aligns executive compensation with shareholder value creation over the long term.
• Employees may view this as a positive sign of the company's commitment to its leadership team.

Key Dates